Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Videnska 1958/9 Prague, Czech Republic.
Transplant Center, Department of Nephrology, Institute for Clinical and Experimental Medicine, Videnska 1958/9 Prague, Czech Republic.
Mediators Inflamm. 2021 Mar 11;2021:5513690. doi: 10.1155/2021/5513690. eCollection 2021.
Kidney allograft transplantation improved the prognosis and quality of life of patients with end-stage renal diseases but the occurrence of acute rejection represents a limitation of the final outcome. Noninvasive biomarkers are needed as well as further advancements in the understanding of immune mechanisms of reaction to the allograft. Our study of 138 patients focused on one-year monitoring of serum concentrations of 12 chemokines regulating the recruitment of different immune cells into transplanted allograft and on regulation of the same chemokines release by interactions of renal proximal epithelial cells with monocyte/macrophage cell line stimulated with TNF alpha. In a group of 44 patients with acute rejection, higher serum pretransplant levels of CXCL1, CXCL5, CXCL6, CCL2, CCL21, and particularly CXCL10 and CX3CL1(both < 0.001) were found suggesting their higher proinflammatory status as compared to subjects with the uncomplicated outcome. In samples collected at the day of biopsy positive for acute rejection, chemokines CXCL9 and CXCL11 attracting preferentially Th1 lymphocytes were found to be upregulated. In our model with TNF alpha induction, renal proximal epithelial cells seemed to be a more potent source of chemokines attracting neutrophils as compared to monocyte/macrophage cell line but the coculture of these cells potentiated release of neutrophilic chemokines CXCL5 and CXCL6. Similar augmentation of chemokine production was found also in the case of CCL2. On the other hand, adding of monocytes/macrophages to a culture of renal epithelial cells suppressed the release of CXCL10 and CXCL11 attracting T lymphocytes. We assume from our data that in kidney allograft transplantation, chemokines attracting neutrophils, T lymphocytes, and monocytes are induced simultaneously and measurement some of them in combination might be used as biomarkers of acute rejection. Mutual cell-cell interactions of immune cells with renal parenchyma seem to be important for fine regulation of chemokine release.
肾移植改善了终末期肾病患者的预后和生活质量,但急性排斥反应的发生限制了最终结果。需要非侵入性生物标志物,以及进一步深入了解免疫反应对移植物的机制。我们对 138 名患者进行了研究,重点是对 12 种趋化因子的血清浓度进行为期一年的监测,这些趋化因子调节不同免疫细胞向移植移植物的募集,并调节肾近端上皮细胞与刺激的单核细胞/巨噬细胞系相互作用释放相同的趋化因子。在 44 名急性排斥反应患者中,发现移植前血清中 CXCL1、CXCL5、CXCL6、CCL2、CCL21 的浓度较高(均<0.001),表明与无并发症患者相比,其炎症状态更高。在活检呈急性排斥反应的样本中,发现趋化因子 CXCL9 和 CXCL11 吸引 Th1 淋巴细胞上调。在我们的 TNF-α诱导模型中,与单核细胞/巨噬细胞系相比,肾近端上皮细胞似乎是吸引中性粒细胞的更有效的趋化因子来源,但这些细胞的共培养增强了中性粒细胞趋化因子 CXCL5 和 CXCL6 的释放。在 CCL2 的情况下也发现了类似的趋化因子产生增强。另一方面,向肾上皮细胞培养物中添加单核细胞/巨噬细胞会抑制趋化因子 CXCL10 和 CXCL11 的释放,吸引 T 淋巴细胞。从我们的数据中,我们假设在肾移植中,吸引中性粒细胞、T 淋巴细胞和单核细胞的趋化因子同时被诱导,并且联合测量其中一些趋化因子可能被用作急性排斥反应的生物标志物。免疫细胞与肾实质的细胞间相互作用对于趋化因子释放的精细调节似乎很重要。